Literature DB >> 18954646

Multimodal evaluation of in vivo magnetic resonance imaging of myocardial restoration by mouse embryonic stem cells.

Stephen L Hendry1, Koen E A van der Bogt, Ahmad Y Sheikh, Takayasu Arai, Scott J Dylla, Micha Drukker, Michael V McConnell, Ingo Kutschka, Grant Hoyt, Feng Cao, Irving L Weissman, Andrew J Connolly, Marc P Pelletier, Joseph C Wu, Robert C Robbins, Phillip C Yang.   

Abstract

OBJECTIVE: Mouse embryonic stem cells have demonstrated potential to restore infarcted myocardium after acute myocardial infarction. Although the underlying mechanism remains controversial, magnetic resonance imaging has provided reliable in vivo assessment of functional recovery after cellular transplants. Multimodal comparison of the restorative effects of mouse embryonic stem cells and mouse embryonic fibroblasts was performed to validate magnetic resonance imaging data and provide mechanistic insight.
METHODS: SCID-beige mice (n = 55) underwent coronary artery ligation followed by injection of 2.5 x 10(5) mouse embryonic stem cells, 2.5 x 10(5) mouse embryonic fibroblasts, or normal saline solution. In vivo magnetic resonance imaging of myocardial restoration by mouse embryonic stem cells was evaluated by (1) in vivo pressure-volume loops, (2) in vivo bioluminescence imaging, and (3) ex vivo TaqMan (Roche Molecular Diagnostics, Pleasanton, Calif) polymerase chain reaction and immunohistologic examination.
RESULTS: In vivo magnetic resonance imaging demonstrated significant improvement in left ventricular ejection fraction at 1 week in the mouse embryonic stem cell group. This finding was validated with (1) pressure-volume loop analysis demonstrating significantly improved systolic and diastolic functions, (2) bioluminescence imaging and polymerase chain reaction showing superior posttransplant survival of mouse embryonic stem cells, (3) immunohistologic identification of cardiac phenotype within engrafted mouse embryonic stem cells, and (4) polymerase chain reaction measuring increased expressions of angiogenic and antiapoptotic genes and decreased expressions of antifibrotic genes.
CONCLUSION: This study validates in vivo magnetic resonance imaging as an effective means of evaluating the restorative potential of mouse embryonic stem cells.

Entities:  

Mesh:

Year:  2008        PMID: 18954646     DOI: 10.1016/j.jtcvs.2007.12.053

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  15 in total

1.  Protein tyrosine phosphatase 1B (PTP1B) is required for cardiac lineage differentiation of mouse embryonic stem cells.

Authors:  Zahra Shokati Eshkiki; Mohammad Hossein Ghahremani; Parisa Shabani; Sattar Gorgani Firuzjaee; Asie Sadeghi; Hossein Ghanbarian; Reza Meshkani
Journal:  Mol Cell Biochem       Date:  2016-11-08       Impact factor: 3.396

2.  The Structural Basis of Functional Improvement in Response to Human Umbilical Cord Blood Stem Cell Transplantation in Hearts With Postinfarct LV Remodeling.

Authors:  Yong Chen; Lei Ye; Jia Zhong; Xin Li; Chen Yan; Margaret P Chandler; Steve Calvin; Feng Xiao; Mesfin Negia; Walter C Low; Jianyi Zhang; Xin Yu
Journal:  Cell Transplant       Date:  2013-12-10       Impact factor: 4.064

3.  Molecular Imaging of Stem Cell Transplantation in Myocardial Disease.

Authors:  Jaehoon Chung; Phillip C Yang
Journal:  Curr Cardiovasc Imaging Rep       Date:  2010-02-03

4.  In vivo molecular MRI of cell survival and teratoma formation following embryonic stem cell transplantation into the injured murine myocardium.

Authors:  Jaehoon Chung; Kehkooi Kee; Joëlle K Barral; Rajesh Dash; Hisanori Kosuge; Xi Wang; Irving Weissman; Robert C Robbins; Dwight Nishimura; Thomas Quertermous; Renee A Reijo-Pera; Phillip C Yang
Journal:  Magn Reson Med       Date:  2011-05-20       Impact factor: 4.668

Review 5.  Role of molecular imaging in stem cell therapy for myocardial restoration.

Authors:  Maarten A Lijkwan; Ernst Jan Bos; Joseph C Wu; Robert C Robbins
Journal:  Trends Cardiovasc Med       Date:  2010-08       Impact factor: 6.677

Review 6.  Whole animal imaging.

Authors:  Gurpreet Singh Sandhu; Luis Solorio; Ann-Marie Broome; Nicolas Salem; Jeff Kolthammer; Tejas Shah; Chris Flask; Jeffrey L Duerk
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Jul-Aug

7.  Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium.

Authors:  Atsushi Tachibana; Michelle R Santoso; Morteza Mahmoudi; Praveen Shukla; Lei Wang; Mihoko Bennett; Andrew B Goldstone; Mouer Wang; Masahiro Fukushi; Antje D Ebert; Y Joseph Woo; Eric Rulifson; Phillip C Yang
Journal:  Circ Res       Date:  2017-07-25       Impact factor: 17.367

8.  Direct evaluation of myocardial viability and stem cell engraftment demonstrates salvage of the injured myocardium.

Authors:  Paul J Kim; Morteza Mahmoudi; Xiaohu Ge; Yuka Matsuura; Ildiko Toma; Scott Metzler; Nigel G Kooreman; John Ramunas; Colin Holbrook; Michael V McConnell; Helen Blau; Phillip Harnish; Eric Rulifson; Phillip C Yang
Journal:  Circ Res       Date:  2015-02-05       Impact factor: 17.367

Review 9.  Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy.

Authors:  Arunima Panda; Narasimman Gurusamy; Sheeja Rajasingh; Hannah-Kaye Carter; Edwin L Thomas; Johnson Rajasingh
Journal:  Differentiation       Date:  2020-01-10       Impact factor: 3.880

10.  Graphite oxide nanoparticles with diameter greater than 20 nm are biocompatible with mouse embryonic stem cells and can be used in a tissue engineering system.

Authors:  I-Ning E Wang; Joshua T Robinson; Grace Do; Guosong Hong; Danny R Gould; Hongjie Dai; Phillip C Yang
Journal:  Small       Date:  2013-12-23       Impact factor: 13.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.